3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 22 0 0 0 0 0 0 0999 V2000
0.5772 1.6819 0.4522 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9696 -1.0114 1.1114 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0744 -0.2318 -0.7542 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4059 0.0908 -0.8549 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8852 -0.5387 0.0641 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1974 0.2238 -0.0282 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2313 0.6293 -0.0783 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1925 1.1872 0.0947 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5447 -1.1205 -0.1051 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5092 0.7580 0.1360 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8905 -1.4464 -0.0549 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2746 -0.3438 0.1256 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6865 0.1217 -0.1084 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9645 2.2461 0.1535 H 1 0 0 0 0 0 0 0 0 0 0 0
-0.8149 -1.9188 -0.1759 H 1 0 0 0 0 0 0 0 0 0 0 0
0.7840 -1.0717 -1.2422 H 0 0 0 0 0 0 0 0 0 0 0 0
2.6827 0.6494 -1.6553 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3228 1.4698 0.2301 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.2138 -2.4810 -0.1046 H 1 0 0 0 0 0 0 0 0 0 0 0
4.8203 1.1060 0.3482 H 0 0 0 0 0 0 0 0 0 0 0 0
4.9072 0.1866 -1.1777 H 0 0 0 0 0 0 0 0 0 0 0 0
5.3836 -0.5883 0.3455 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 2 0 0 0 0
2 12 2 0 0 0 0
3 4 1 0 0 0 0
3 7 1 0 0 0 0
3 16 1 0 0 0 0
4 12 1 0 0 0 0
4 17 1 0 0 0 0
5 10 2 0 0 0 0
5 11 1 0 0 0 0
6 7 1 0 0 0 0
6 8 2 0 0 0 0
6 9 1 0 0 0 0
8 10 1 0 0 0 0
8 14 1 0 0 0 0
9 11 2 0 0 0 0
9 15 1 0 0 0 0
10 18 1 0 0 0 0
11 19 1 0 0 0 0
12 13 1 0 0 0 0
13 20 1 0 0 0 0
13 21 1 0 0 0 0
13 22 1 0 0 0 0
M ISO 4 14 2 15 2 18 2 19 2
4. 国际命名与标识
4.1 IUPAC Name
N'-acetyl-2,3,5,6-tetradeuteriopyridine-4-carbohydrazide
4.2 InChl
InChI=1S/C8H9N3O2/c1-6(12)10-11-8(13)7-2-4-9-5-3-7/h2-5H,1H3,(H,10,12)(H,11,13)/i2D,3D,4D,5D
4.3 InChlKey
CVBGNAKQQUWBQV-QFFDRWTDSA-N
4.4 Canonical SMILES
CC(=O)NNC(=O)C1=CC=NC=C1
4.5 lsomeric SMILES
[2H]C1=C(N=C(C(=C1C(=O)NNC(=O)C)[2H])[2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病